Abstract:This study aimed to develop a solid dispersion formulation of silymarin (Silymarin-SD) using freeze-drying method to enhance its oral bioavailability (BA) by inhibiting the intestinal first-pass effect and increasing its solubility and permeability. Silymarin-SD formulation (i.e., silymarin:tween 80:hydroxypropyl cellulose (HPC) = 1:1:3 (w/w/w) significantly increased silymarin permeability in the duodenum, jejunum, and ileum by decreasing the efflux ratio of silymarin and by inhibiting silymarin-glucuronidation activity, in which tween 80 played a crucial role. As a result, orally administered Silymarin-SD formulation increased plasma silymarin concentrations and decreased silymarin-glucuronide in rats compared with silymarin alone and silymmarin: d -α-tocopherol polyethylene glycol 1000 succinate (1:1, w/w) formulation. In addition to modulating intestinal first-pass effect, Silymarin-SD formulation showed a significantly higher cumulative dissolution for 120 min compared with that of silymarin from the physical mixture (PM) of the same composition as Silymarin-SD and silymarin alone; the relative BA of silymarin-SD increased to 215% and 589% compared with silymarin-PM and silymarin alone, respectively. This could be attributed to the amorphous status of the Silymarin-SD formulation without chemical interaction with excipients, such as tween 80 and HPC. Moreover, the hepatoprotective effect of Silymarin-SD in acetaminophen-induced acute hepatotoxicity, as estimated from the alanine aminotransferase and aspartate aminotransferase values, was superior to that of silymarin. In conclusion, the increase in the dissolution rate and intestinal permeability of silymarin, and the inhibition of silymarin-glucuronidation by the Silymarin-SD formulation, prepared using tween 80 and HPC, increased its plasma concentration and resulted in a superior hepatoprotective effect compared to silymarin.

Preparation of silymarin suspension and evaluation of its stability and release

Silymarin Glyceryl Monooleate/Poloxamer 407 Liquid Crystalline Matrices: Physical Characterization and Enhanced Oral Bioavailability

Preparation and in Vitro and in Vivo Evaluation of Silymarin Self-Microemulsifying Concentrated Microemulsion

Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin.

A comparative study on the preparation and evaluation of solubilizing systems for silymarin

Synchronized and sustained release of multiple components in silymarin from erodible glyceryl monostearate matrix system.

Enhanced bioavailability and hepatoprotective effect of silymarin by preparing silymarin-loaded solid dispersion formulation using freeze-drying method

Enhanced Dissolution of Silymarin/polyvinylpyrrolidone Solid Dispersion Pellets Prepared by a One-Step Fluid-Bed Coating Technique

Enhanced Bioavailability of Silymarin by Self-Microemulsifying Drug Delivery System

Development of Silymarin Self-Microemulsifying Drug Delivery System with Enhanced Oral Bioavailability

Study on pramipexole dihydrochloride sustained-release tablets

Optimized Preparation of Silymarin Dropping Pill by a Central Composite Design-Response Surface Method

Formulation of Microemulsion Systems for Dermal Delivery of Silymarin

<i>In vitro</i>and<i>in vivo</i>evaluation of silybin nanosuspensions for oral and intravenous delivery

Delivery of Silybin Using a Zein-Pullulan Nanocomplex: Fabrication, Characterization, in Vitro Release Properties and Antioxidant Capacity

Preparation, Characterization and Evaluation of Flavonolignan Silymarin Effervescent Floating Matrix Tablets for Enhanced Oral Bioavailability

Synchronized and Controlled Release of Multiple Components in Silymarin Achieved by the Osmotic Release Strategy

A Comparative Study on the Stability of Silybin and That in Silymarin in Buffers and Biological Fluids

In vitro and in vivo evaluation of a self-microemulsifying drug delivery system for silybin

In vitro evaluation and pharmacokinetics in dogs of solid dispersion pellets containing Silybum marianum extract prepared by fluid-bed coating.

Nanocrystal Formulation to Enhance Oral Absorption of Silybin: Preparation, In Vitro Evaluations, and Pharmacokinetic Evaluations in Rats and Healthy Human Subjects